Anjalee Khemlani

· 4 min read Gilead Sciences ( GILD ) increased its growth forecast for the year on strong third quarter results, marking a shift

Novavax's ( NVAX ) stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for the year.

Anjalee Khemlani · Senior Reporter 3 min read In This Article

· 3 min read Hims & Hers ( HIMS ) is launching a new GLP-1 tracker in its efforts to fight back against the FDA's decision to end compounded GLP-1s on the market.

Anjalee Khemlani · Senior Reporter 3 min read In This Article

· 3 min read Vaccine and other healthcare stocks fell Friday after President-elect Donald Trump said Robert F.

President-elect Donald Trump has selected Robert F. Kennedy Jr. for the position of Secretary of Health & Human Services (HHS). The appointment has drawn significant attention due to Kennedy Jr.'s controversial stance on vaccines, including his designation as one of the "Disinformation Dozen" during the COVID-19 pandemic. Following the announcement, vaccine-related stocks experienced a notable decline. Yahoo Finance Senior Health Reporter Anjalee Khemlani analyzes the implications of this appointment and shares reactions from market analysts regarding its potential impact on the healthcare sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Another Jefferies analyst, Michael Yee, said that RFK has not provided drastic solutions, but has rather been skeptical of the regulatory process.

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market.

Anjalee Khemlani · Senior Reporter 4 min read In this article President-elect Donald Trump's nomination of Robert F.